v3.23.1
Equity Awards
 12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Share-Based Payment Arrangement [Text Block]

Note 14 – Equity Awards

 

The following table sets forth information on outstanding option and stock awards held by the named executive officers of the Company on December 31, 2021, and December 31, 2020, including the number of shares underlying both exercisable and un-exercisable portions of each stock option as well as the exercise price and the expiration date of each outstanding option. See Note to Notes to Consolidated Financial Statements.

 

Outstanding Equity Awards After Fiscal Year-End (1)

Name

 

Number of securities underlying unexercised

options exercisable (1)

 

 

 

Number of securities underlying unexercised

options un-exercisable (2)

 

 

Option Exercise Price ($)

 

 

Option Grant Date

 

 

Option Expiration Date

Michael Mildebrandt

 

 

3,704

 

(3)(4)

 

 

8

 

 

$

.001

 

 

11/01/2019

 

 

11/01/2023

Adrian Balinski

 

 

3,704

 

(3)(4)

 

 

8

 

 

$

.001

 

 

11/01/2019

 

 

11/01/2023

 

  (1) 7,408 shares were issued for Equity Awards during the year ended December 31, 2020.

 

(2)

All options vest 20% per year beginning on the first anniversary of their grant date.

 

(3)

Messrs. Mildebrandt and Balinski were each awarded 3,704 shares of restricted common stock as of October 31, 2020, for being officers and directors of the Company.

 

(4)

Messer’s. Mildebrandt and Balinski have resigned as officers and directors.

 

An aggregate of 7,408 stock awards is outstanding under the Equity Incentive Plan (“EIP”) as of December 31, 2022. An aggregate of 5,000,000 stock awards were issued in 2021, of which, 3,500,000 were held by Consultants controlled by Mr. Shorey, 500,000 were held by Mr. Marx and 1,000,000 which are held by an unrelated consultant.